Legal & General Group
SRRA

Legal & General Group’s Sierra Oncology, Inc. Common Stock SRRA Stock Holding History

Legal & General Group’s Portfolio SRRA Stock Details SRRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-2,192
Closed -$121K – 3546
2022
Q2 		$121K Buy
+2,192
New +$115K ﹤0.01% 2802

Other funds holding SRRA

HI
Harbour Investments Madison, Wisconsin $6.48B AUM 18.23% 1-Year Est. Return

Legal & General Group's SRRA Position: Q3 2022 in Review

Legal & General Group sold out of Sierra Oncology, Inc. Common Stock (SRRA) in Q3 2022, closing a stake of 2,192 shares — an estimated $121K sold.

Legal & General Group first reported a position in SRRA in Q2 2022 and held it in 1 quarter. The position peaked at $121K in Q2 2022. 1 fund tracked by Wall St. Rank holds SRRA as of Q3 2022.

  • Legal & General Group reported no remaining Sierra Oncology, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • Legal & General Group sold 2,192 Sierra Oncology, Inc. Common Stock shares in Q3 2022, an estimated $121K.
  • Legal & General Group first reported a position in Sierra Oncology, Inc. Common Stock in Q2 2022 and held it in 1 quarter.
  • Legal & General Group's Sierra Oncology, Inc. Common Stock position peaked at $121K in Q2 2022.
  • 1 fund tracked by Wall St. Rank held Sierra Oncology, Inc. Common Stock as of Q3 2022.

Based on Legal & General Group's 13F filing for Q3 2022, filed 14 Nov 2022.